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Abstract
Two-component systems, composed of a sensor histidine kinase and an effector response regulator (RR), are the main signal
transduction devices in bacteria. In Bacillus, the Rap protein family modulates complex signaling processes mediated by
two-component systems, such as competence, sporulation, or biofilm formation, by inhibiting the RR components involved
in these pathways. Despite the high degree of sequence homology, Rap proteins exert their activity by two completely
different mechanisms of action: inducing RR dephosphorylation or blocking RR binding to its target promoter. However the
regulatory mechanism involving Rap proteins is even more complex since Rap activity is antagonized by specific signaling
peptides (Phr) through a mechanism that remains unknown at the molecular level. Using X-ray analyses, we determined the
structure of RapF, the anti-activator of competence RR ComA, alone and in complex with its regulatory peptide PhrF. The
structural and functional data presented herein reveal that peptide PhrF blocks the RapF-ComA interaction through an
allosteric mechanism. PhrF accommodates in the C-terminal tetratricopeptide repeat domain of RapF by inducing its
constriction, a conformational change propagated by a pronounced rotation to the N-terminal ComA-binding domain. This
movement partially disrupts the ComA binding site by triggering the ComA disassociation, whose interaction with RapF is
also sterically impaired in the PhrF-induced conformation of RapF. Sequence analyses of the Rap proteins, guided by the
RapF-PhrF structure, unveil the molecular basis of Phr recognition and discrimination, allowing us to relax the Phr specificity
of RapF by a single residue change.
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Introduction
Bacteria communicate with each another and coordinate
essential processes such as biofilm formation, sporulation, compe-
tence, virulence, or swarming motility in different ways. Quorum
sensing is one of these mechanisms regulated by cell population
density, and is mediated by self-generated extracellular signal
molecules to allow the coordination of community-wide behaviors.
Both Gram-negative and Gram-positive bacteria exploit quorum-
sensing signaling, generally through different messenger molecules.
In the former, acyl-homoserine lactones are the predominant
signals, whereas the quorum sensing in the latter relies on the
secretion and recognition of oligopeptides. These signaling
peptides elicit a response either directly by interacting with their
intracellular receptor after an importing process or indirectly by
modulating the activity of a membrane-bound two-component
sensor histidine kinase in the responder cell [1–3].
The RNPP family (named after its members: Rap/NprR/PlcR/
PrgX) of quorum-sensing proteins comprises Gram-positive regulators,
which bind directly to their signaling peptide in the receiver cell [4,5].
Structural and functional data indicate that the members of this family
share a similar architecture, which is composed of an N-terminal
effector domain that interacts with the target and a C-terminal
regulatory domain that recognizes the oligopeptide [4,6–12]. Three
(NprR, PclR, and PrgX) of the four RNPP family members present an
effector domain, which adopts the characteristic DNA-binding helix-
turn-helix (HTH) fold and exerts its activity by directly interacting with
DNA [4,8,9]. In contrast, the N-terminal domain of Rap proteins folds
as a 3-helix bundle that mediates their action by interacting with their
targets [6,7], which, in most cases, are the two-component signaling
protein response regulators (RR). RNPP regulatory domains contain
from five (PlcR) to nine (NprR) degenerated tetratricopeptide repeats
(TPRs) [8]. TPRs are helical domains that mediate protein-protein
interactions and the assembly of multiprotein complexes [13]. The
TPR motif consists of 34 amino acid residues with a poorly conserved
consensus sequence. Structurally, TPR motifs fold as two antiparallel
a-helices, denoted helix A and helix B, which adopt a helix-turn-helix
arrangement. Usually, several TPR motifs pack in a parallel fashion to
generate a right-handed superhelix with an internal concave surface,
mainly contributed by the residues in helices A [13]. For some RNPP
family members, it has been shown that the recognition and binding of
signaling peptides is mediated by the TPR [4,8,9,11]. However, the
binding of signaling peptides to each RNPP representative seems to
have dissimilar effects since PlcR and NrpR are activated, but Raps
and PrgX are inhibited by their corresponding oligopeptides [8,12,14–
16].
Rap proteins have been exhaustively studied in Bacillus subtilis,
which expresses 11 chromosomal- and five plasmid-encoded
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members [17–21]. Several Rap proteins block the signaling
mediated by the two-component system by interacting with
RRs. However, two completely different ways of accomplishing
this function have been reported for members of this family. One
subset of Rap proteins, including RapA, RapB, RapE, RapH, and
RapJ, displays phosphatase activity to their target RRs
[6,7,15,19,21,22]. The second subgroup, comprising RapC, RapF,
RapG, RapH, and RapK, blocks the action of the target RR by a
direct interaction with their DNA binding domain, and works as
an anti-activator [6,21,23–25]. Interestingly, RapH possesses both
activities [21]. The complexity of the Rap signaling system
increases by the participation of the aforementioned regulatory
oligopeptides. For Rap proteins, regulatory peptides are called Phr
and their mature active form is a penta- or hexa-peptide generated
from a ,40 amino-acid precursor by means of a post-transcrip-
tional export-import process [16,22,26–28]. Phr peptides are
commonly linked to their target Rap proteins in such way that phr
genes are situated immediately downstream of the genes encoding
the Rap proteins to form rap-phr signaling cassettes, which are
concurrently transcribed [3]; thus, the Phr peptide is named after
the Rap protein. Eight (RapA, RapC, RapE, RapF, RapG, RapH,
RapI, and RapK) of the 11 genome-encoded Raps in B. subtilis
form rap-phr signaling cassettes. RapB is regulated by the RapC
(PhrC) peptide, while RapD and RapJ remain as Phr orphan Raps
[3,16].
Recently, the tridimensional structure has been reported of two
Rap family members, RapF and RapH, in complex with their RR
targets, ComA (DNA binding domain) and Spo0F, respectively
[6,7]. These structures have revealed that RapF and RapH are
structurally similar, but that they bind their cognate RR at distinct
non overlapping sites, mainly localized in the 3-helix bundle N-
terminal domain of both proteins [6,7]. Since it is anticipated that
Phr peptides are recognized by the C-terminal TPR domain [29],
it has been proposed that the inhibition of Rap proteins by the
signaling peptides could be mediated by Phr-induced conforma-
tional changes [6]. In order to demonstrate how Rap proteins
inhibition is accomplished by Phr peptides, we determined the
tridimensional structure of B. subtilis RapF alone and in complex
with its cognate inhibitory pentapeptide PhrF. The structures show
that the TPR domain of RapF recognizes and binds the PhrF
peptide, and that six of the seven TPR motifs in this domain
participate in the process. The sequence analysis of the Rap
proteins guided by the free and RapF-PhrF structures allow us to
identify critical positions in the Rap-Phr interaction and to unveil
two types of residues responsible for mediating either peptide
anchoring or peptide selectivity. The comparison of RapF-PhrF,
RapF-free, and RapF-ComA reveals major movements in RapF
induced by PhrF and provides a mechanistic insight into the
molecular basis of Rap protein inhibition by signaling peptides.
Results
Overall Structure of RapF and RapF-PhrF Complex
In order to determine the molecular basis of RapF inhibition by
Phr peptides, the X-ray structures of RapF alone and in complex
with its inhibitory pentapeptide PhrF (QRGMI) were determined.
The structures were solved using the anomalous signal of the
selenium or platinum atoms for the apo or the PhrF complex
structures, respectively (Table S1). The crystal asymmetric unit
showed two molecules in the free RapF structure and one RapF
molecule bound to one PhrF peptide in the structure of the
complex. The structural models for the free and PhrF complex
forms were refined to a final resolution of 2.25 and 3.1 A˚,
respectively (Figure 1A–1C; Table S1). Despite the limited
resolution data for the RapF-PhrF complex, density maps of
exceptional quality were obtained from the experiential phases
and improved by density modification due to the high-solved
content (75%) of the crystals (Figure S1). The RapF protein model,
the PhrF peptide, and the contact described herein were clearly
visible in these maps, except for the nine C-terminal residues
(residues 376–381) where electronic density was absent, which
reflects the elevated flexibility of this region.
As previously disclosed by the crystal RapF structure in complex
with the DNA-binding domain of its RR target ComA [6], RapF
was an all-helical protein consisting of two domains: a small N-
terminal 3-helix bundle domain (residues 1–68) and a large C-
terminal TPR domain (residues 98–370), both connected by a
linker region (69–97) (Figure 1). The RapF-ComA structure
showed that the 3-helix bundle, together with the linker region,
formed the ComA binding surface (Figure 1D). A comparison of
the free RapF and the RapF-ComA structure reveals that binding
of ComA to RapF only promoted slight local conformational
changes in RapF, which were mainly restricted to the RR
recognition domain (the 3-helix bundle plus the linker region; 1–
97) in order to bind the DNA binding helix of ComA (Figures 1C,
1D, and S2). The core TPR domains remained at the same
position (root mean square = 0.66 A˚ for the superimposition of
residues 98–380; Figure S2), which supports that RapF in solution
presents an active conformation that is competent to bind ComA.
Since RapF presented a similar conformation in the free and the
ComA complex forms (Figure S2), here we discuss the conforma-
tional changes observed in the RapF-PhrF complex with regard to
the structure of both RapF-ComA and RapF-free indistinctly. The
RapF-PhrF structure reveals that the inhibitory peptide was bound
to the TPR domain (Figure 1A). The most striking difference
Author Summary
In microorganisms, two component signaling systems are
widely used to sense and respond to environmental
changes, including quorum-sensing of Phr oligopeptides.
Although the minimal machinery required for these
systems comprises a sensor histidine kinase and an
effector response regulator (RR), ancillary proteins, termed
‘‘connectors,’’ capable of modulating the activity of this
machinery, are emerging as additional players in this
complex signaling process. Rap proteins are archetypal
connectors, able to modulate the activity of RRs either by
dephosphorylating them or by physically blocking them.
Rap proteins are themselves in turn inhibited by specific
Phr peptides, adding an extra level of complexity, but how
a Rap protein is regulated by its cognate Phr peptide
remains unknown. To answer this question, we solved the
structure of RapF, a Rap family member that blocks RR
ComA, alone and in the complex with its inhibitory
peptide PhrF. Our structural and functional results reveal
that PhrF blocks the RapF-ComA interaction by an
allosteric mechanism since the PhrF-RapF interaction
induces a conformational change that is propagated to
the the ComA binding site, disrupting it and triggering the
dissociation of ComA from RapF. Using sequence analysis
guided by our structure, we pinpointed sets of residues
responsible for peptide anchor and specificity, respective-
ly, and were able to relax RapF-Phr specificity simply by
changing a single residue. Knowledge of these key
residues and the Rap inhibition mechanism opens up the
possibility of re-engineering Rap proteins, and paves the
way to reprogramming signaling pathways for biological
and biotechnological applications.
Phr-Mediated Rap Inhibition
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between the RapF structures was the relative disposition of the N-
and C-terminal domains. When RapF was free or in complex with
ComA, the 3-helix bundle domain was projected apart from the
TPR domain, thus exposing the ComA binding surface. In
contrast, this domain retracted and was laid on the TPR domain
when PhrF was bound (Figure 1B–1D). The most affected
structural elements by PhrF-induced movements were the C-
terminal part of the a3 helix in the 3-helix bundle domain and the
connected linker region. The 3-helix bundle a3 helix was five
residues shorter in the RapF-PhrF structure. Moreover these
residues, together with the 310 helix of the linker region observed
in the RapF-ComA structure, formed a long unstructured loop in
the complex with the peptide (Figures 1B–1D).
PhrF Binding Site
The RNPP family of Gram-positive quorum sensors presents a
characteristic C-terminal TPR domain with seven TPR repeats for
the structurally known Raps (RapF and RapH) (Figures 1E and
S3) [30,31]. The RapF TPR domain folded in a large superhelix to
generate a pseudo circular structure that was closed in a wide
channel (8,588 A˚3, calculated by the CASTp software [32]) by the
interaction of the terminal part of TPR7 (and the following C-
terminal tail) with the initial part of TPR1 (Figure 1). As a channel,
the generated ring-like structure was open on both faces (Figures
S4, upper panel). PhrF placed on the concave side of the RapF
TPR channel, similarly to that observed for PlcR and PrgX, two
RNPP representatives, in complex with their regulatory peptides
(PapR and cCF10, respectively) (Figures 1A, 1B, and S3) [4,9].
Peptide binding to RapF induced a severe constriction in the TPR
channel (volume lowered to 4,954 A˚3) and a large displacement of
the 3-helix bundle domain (see below), which partially closed one
of the channel faces (Figures 1B, 1D, and S4, lower panel). PhrF
lies in an extended conformation, as described for several TPR-
peptide complexes [13], and interacted with the residues of six of
the seven TPR repeats (TPR2–TPR7) (Figures 1 and 2).
Additionally, the interaction of Tyr66 from the 3-helix bundle
with the PhrF carboxy-terminus was the unique contact between
this domain and the peptide, and accounted for the requirement of
the free terminal carboxylate group described for the PhrA
inhibition of RapA [33]. A comparison of the peptide-free and
bound RapF structures showed that TPR4–TPR7 generated a
preformed site (minimum displacement between both structures)
where the peptide was positioned (see below). The central part of
the peptide main chain was fixed by polar interactions. In
particular, the strictly conserved Asn in the RNPP superfamily
(Figures 1E and 2), Asn227 in RapF, emerged from TPR4 to bind
by a hydrogen bond with PhrF Met4, and a Rap family conserved
TPR2 Tyr (Tyr152 in RapF) bound the main chain oxygen of
PhrF Gly3 (Figures 1E and 2). The peptide adopted its extended
conformation by pulling interactions from both the N- and C-
terminal ends. The C-terminal PhrF oxygens interacted with
Arg223 (TPR4) by a salt bridge, and with Gln183 (TPR3) and
Tyr66 (3-helix bundle) by both hydrogen bonds. On the opposite
end, Asp338 from TPR7 was salt-bridged with N-terminal PhrF
nitrogen (Figure 2). The PhrF side chains, with the obvious
exception of Gly3, established extensive contacts with the less
conserved TPR residues in the Rap family. PhrF Gln1 was
hydrogen-bound to Tyr226 (TPR4) and Tyr300 (TPR6), and
came into hydrophobic contact with the side chains of Gln263 and
Phe266 on TPR5 (Figure 2). The side chain of PhrF Arg2 was
situated in a hydrophobic pocket formed by Tyr152, Lys155 (both
from TPR2), and Ala334 (TPR7), which was closed by the
conserved Asp194 (TPR3), which interacted with Arg2 via a salt
bridge (Figure 2). Similarly, PhrF Met4 and Ile5 were inserted into
the hydrophobic clefts generated by the side chains of Tyr226
(TPR3), Phe252 (TPR4), and Gln263 (TPR5) for Met4, and
Phe145, Glu149, Tyr153 (all from TPR2), and Leu187 (TPR3) for
Ile5, with Arg223 (TPR4) participating at both sites (Figure 2).
Decoding Phr Binding and Specificity
In accordance with the contacts described in the previous
sections, the residues involved in Phr peptide binding and
recognition were grouped into two sets. The first set should
include those interactions anchoring the peptide onto the TPR
domain to ensure that the peptide sets the protein in a correct
orientation and to guarantee the extended conformation. The
second set should correspond to the variable residues in the Rap
family, which confer specificity among peptides.
Peptide anchoring should be independent of its sequence. Thus,
it is primarily mediated by interactions with the peptide main
chain. These interactions are mainly polar in nature and involve
the side chain hydrogen bonds and salt bridges of Tyr66, Tyr152,
Gln183, Arg223, Asn227, Gln263, and Asp338 with the PhrF
backbone (Figure 2). Additionally, the conserved Arg at position 2
of the Phr peptides is anchored by a salt bridge with the side chain
of a conserved Asp residue (Asp194 in RapF) from TPR3
(Figure 2). This side-chain side-chain interaction was expected to
be preserved between Raps and Phrs as both positions were strictly
conserved, except for the PhrG-RapG pair where conservative Arg
to Lys (PhrG) and Asp to Glu (RapG) changes were observed
(Figure 2B), changes that should maintain the salt bridge. Previous
mutagenic assays have demonstrated the pivotal role of these
residues in peptide recognition and binding [11,19,25]. The
position occupied by Asn227 in RapF was strictly conserved in the
RNPP family (Figures 1E and 2B) and its mutation to alanine in
RapA yielded a protein with impaired capacity to bind the PhrA
peptide, but with intact capacity to bind its target RR Spo0F [11].
Furthermore, peptide backbone recognition mediated by aspara-
Figure 1. Structure of RapF-PhrF, RapF free, RapF-ComA, and structure-guided sequence alignment of RNPP family members. (A)
Ribbon representations of RapF-PhrF complex in three orthogonal views. The 3-helix bundle is colored in yellow, the linker region in red, and the TPR
domain in light blue. PhrF is shown in sticks rendering with carbon atoms colored in magenta. (B–D) Conformations of RapF. Ribbon models of the
three forms of RapF, (B) PhrF complex, (C) free, and (D) ComA complex (Protein Data Bank entry 3ULQ), are shown in the same orientation with the 3-
helix-bundle colored in yellow, the linker region in red, and the TPR1 in light purple, TPR2 in dark purple, TPR3 in dark blue, TPR4 in cyan, TPR5 in light
blue, TPR6 in orange, and TPR7 in olive. In the RapF-ComA structure, ComA DNA binding domain is represented in ribbon and colored in pale green.
(E) Sequences of four B. subtilis Rap family members and PlcR (TPR domain only) from B. cereus are aligned guided by the structures when were
available (RapF, present study and PDB= 3ULQ; RapH, PDB=3Q15; and PlcR, PDB=2QFC). The secondary structure elements for RapF in complex with
ComA and PhrF are represented above the sequence, named and colored as in (B) and (D). Black lines indicate the TPR helices as obtained from the
PlcR structure. The residues interacting with PhrF are surrounded by red boxes and white lettering for RapF sequence. PlcR residues implicated in
PapR binding are highlighted with pink shadows [4]. Residues highlighted in green and blue at RapF and RapH sequences, respectively, are
implicated in the RR binding [6,7]. Substitutions at the positions highlighted by purple lettering in the sequence of RapC and RapA abolished peptide
binding [11,19,25]. Black starts indicate residues substituted in the present works that abolish or alter the peptide binding. The blue arrowhead points
the trypsin cut position and the sequence obtained after Edman sequencing of the major tryptic fragment is underlined in blue.
doi:10.1371/journal.pbio.1001511.g001
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gine interactions has been reported to be a conserved feature of
either prokaryotic or eukaryotic TPR domains [4,11,13]. To
confirm these observations, RapF Asn227 to Ala mutant was
generated (RapFN227A) and its PhrF binding capacity was checked
by a native gel electrophoresis assay. The electrophoretic mobility
of RapF is altered upon PhrF binding and the RapF-PhrF complex
presents faster mobility than RapF alone when employing native
gels (Figure 3A) [34]. In the case of RapFN227A, no shifted bands
were observed after incubation with PhrF (Figure 3A). Since RapF
and RapFN227A were similarly capable of interacting with their
Figure 2. PhrF recognition by RapF. (A) Close view of the PhrF binding site that is presented in two halves dissected along the peptide axis for
easier visualization. Colors are as in Figure 1B. Peptide interacting residues are shown in stick, labeled and colored with the carbon atoms as the
corresponding structural element. PhrF is shown in sticks, labeled and colored with carbon atoms in pink. RapF-PhrF polar interactions are drawn as
dashed black lines. (B) Peptide interacting residues in Rap proteins from B. subtilis. Residues for the 11 Rap proteins from B. subtilis corresponding to
the RapF positions interacting with PhrF are aligned. Anchor and specificity residues are highlighted by magenta and light blue boxes, respectively.
The numbers indicate amino acid positions of RapF. (Right) For each Rap protein the corresponding Phr Inhibitory peptide is shown. The conserved
positive charged residue at position 2 is highlighted in mustard.
doi:10.1371/journal.pbio.1001511.g002
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target protein ComA (Figure 3A), it would seem that the protein
folding and stability of RapF were not compromised by the
mutation. Indeed, PhrF had no effect on the RapFN227A binding to
ComA (Figure 3A), thus supporting the key role of this conserved
residue in Phr-Rap recognition and the separate location for the
Phr and ComA sites. The anchor role revealed by the RapF-PhrF
complex for the positions occupied by Asp194 and Gln263 has
been previously reported for RapA and RapC. Mutations of the
equivalent positions in RapA (Asp192 and His260, respectively)
generated variants that were insensitive to the inhibitory activity of
PhrA, but with the unaffected ability to promote Spo0F,P
dephosphorylation [19,35]. Equivalent mutations in RapC
(Asp195 and Pro263 to Asn and Leu, respectively) also disrupted
peptide binding, thus confirming the critical role of these positions
to establish interactions that allow a complex formation between
Raps and their inhibitory peptide [25]. The anchor function for
Asp194 in RapF was confirmed by generating an Ala mutant in
this position (RapFD194A). Similarly to RapFN227A, the mutation of
Asp194 disrupted the capacity of RapF to bind PhrF, but had no
effect on the binding to ComA (Figure 3A), thus validating the
PhrF-bound structure and the proposed anchor role for this
residue.
Given their conservation, anchor residues should play a minor
role in discriminating inhibitory peptides. The ability to distinguish
different inhibitory peptides should be conferred by the variable
residues among Rap proteins, which recognized particular side
chains of each inhibitory peptide. Therefore, we propose that the
residues described in the previous section (Figure 2B, residues
highlighted in light blue), which interacted with the RapF side
chains, would work as ‘‘specificity’’ residues. To confirm our
hypothesis, and as a case in point, the RapF, RapB, and RapC
sequences were compared and the positions that would mediate
peptide specificity, guided by the RapF-PhrF structure, were
mapped (Figures 2B and 4). RapC and RapB were inhibited by
PhrC (ERGMT) [16], which differed from PhrF in terms of its first
and last positions (QRGMI). Therefore, a search was made among
the proposed specificity residues for those that interacted with
positions 1 and 5 of PhrF, which were identical in RapB and
RapC, but changed in RapF (Figures 2 and 4). A strong candidate
residue was Glu303, which interacted with PhrF Gln1 by a
hydrogen bond. This residue was substituted by a Lys in RapC
and RapB, which could interact by a salt bridge with PhrC Glu1
(Figures 2, 4, and S5). Indeed, similar Lys–Glu (Rap-Phr) couples
were observed for RapG and RapK, and also for their inhibitory
peptides, PhrG and PhrK, respectively (Figure 2B). Furthermore,
RapI, whose inhibitory peptide PhrI had an acidic (Asp) residue at
position 1, also presented a Lys at this position (Figure 2B). The
RapF mutant forms of Glu303 to Ala (RapFE303A) and Lys
(RapFE303K) were constructed by the latter mutation emulating the
residue observed in other Raps, and the peptide binding capacity
of these forms was tested by native gel electrophoresis. As seen in
Figure 3A, RapFE303K was able to bind PhrC, but RapFE303A did
not display this ability; this scenario supports the prominent role of
this position in peptide recognition. Both Glu303 mutants
preserved their ability to bind ComA, but this ability was inhibited
by PhrC with RapFE303K, but not with RapFE303A (Figure 3A).
This is in close agreement with the PhrC binding capacity of each
RapF mutant and indicates that peptide binding and the induced
conformational changes are similar to those produced by PhrF.
Interestingly, PhrF interacted with both RapF Glu303 mutants
(Figures 3A), suggesting that RapFE303K Lys could maintain the
interaction with PhrF Gln1, and in the case of RapFE303A, the
absence of this contact did not suffice to abolish the RapF-PhrF
interaction (at least not under our experimental conditions).
Thermal-shift assays were used to further confirm the peptide
binding capacity of each mutant. PhrF induced a strong
stabilization of RapF with an increment in the melting temper-
ature of ,20uC (from 49.5uC to 69.3uC), which supports peptide
binding to the protein (Figure 3B). Unlike PhrF, non RapF partner
peptides PhrA, PhrC, and PhrE presented identical melting
transitions to those observed in the absence of peptide (Figure 3B
and unpublished data), indicating the lack of RapF-peptide
interaction. Similarly, the denaturation temperature for the
RapFN227A and RapFD194A mutants was unaltered by PhrF or
Figure 3. In vitro analysis of RapF and RapF mutants
interaction with peptides and ComA. (A) Native gel assays. The
interaction of native RapF and the RapF mutants Asn227Ala (RapFN227A),
Asp194Ala (RapFD194A), Glu303Lys (RapFK303A), and Glu303Ala (Rap-
FE303A) with the inhibitory peptides PhrF and PhrC and the RR ComA
were analyzed by Native-PAGE and Coomassie-stained. The positions of
the individual proteins and the peptide-Rap or ComA-Rap complexes
are indicated by black arrowheads and labeled. (B) Thermal-shift assays.
Representative thermal denaturation curve profiles of wild type and
mutant variants in the absence (_) or the presence of PhrF (—) and PhrC
(????) as monitored by Sypro orange fluorescence. The Tm values from at
least three independent experiments performed in duplicated are
indicated.
doi:10.1371/journal.pbio.1001511.g003
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PhrC (Figure 3B), which was expected for the mutations that
abolish peptide binding. The RapFE303K mutant was stabilized by
PhrF and PhrC (Figure 3B), which reveal this mutant’s capacity to
bind both peptides and the peptide specificity reduction by this
mutation. The thermal denaturation of RapFE303A also confirmed
the previous electrophoretic results, showing that PhrF, but not
PhrC, stabilized the protein (Figure 3B). As anticipated by their
capacity to interact with ComA, this analysis also confirms that the
mutations had no deleterious effect on protein folding or stability
as all the proteins presented a similar melting point when the
peptide was absent (Figure 3B).
Quantitative Analysis of the RapF-PhrF Interaction
To quantify the effect on the Phr peptide binding of the RapF
mutations described in the previous section, we calculated the
apparent binding affinity (Kd) for Phr peptides by gel shift assays.
Titration of RapF with PhrF showed that less than 30% of RapF
was present in the free form at a concentration of 12 mM PhrF
(Figure 5A, upper panel), and a Kd value of 3.1 mM for the PhrF
peptide was calculated. In contrast, the PhrF-protein complex was
not observed for the RapFN227A or RapFD194A mutants, even if the
peptide was present at concentrations as high as 1.2 mM
(Figure 5A, upper panel). Therefore, these point mutations
abolished the peptide-binding capacity of RapF supporting their
anchor role proposed herein. A similar analysis of the RapFE303K
and RapFE303A mutants confirms the key function for the residue
at position 303 in the peptide selection since its mutation to Lys,
but not to Ala, conferred RapF the previously absent capacity of
PhrC binding (Figures 3 and 5A). Quantification of this interaction
showed a Kd of 19.6 mM for the binding of PhrC to RapF
E303K,
which was only ,6 times lower than that calculated for RapF-
PhrF (Figure 5A). This finding indicates that the Rap-Phr
interaction was the result of a complex set of interactions, many
of which were common for PhrC and PhrF, but some positions
contributed more in selecting the peptide by recognizing the
distinctive peptide positions. The quantification of PhrF binding to
the Glu303 mutants supports the ‘‘specificity’’ character of this
position since its change to a residue, which eliminated the
interaction with the peptide as Ala, only reduced (,10 times; Kd
29 mM), but did not abolish, the binding capacity of RapF; this
was the case of the equivalent substitutions at anchor positions
Asp277 and Asp194 (Figure 5A). In addition, the substitution of
Glu303 by Lys, a residue that was still able to maintain the
interaction with PhrF Gln1, only diminished the binding affinity
(Kd 13.2 mM) for this peptide by ,4 times in relation to the wild-
type protein (Figure 5A).
RapF Conformational Changes Induced by PhrF Binding
A comparative analysis of the RapF structures revealed major
conformational changes upon peptide binding. PhrF accommo-
dation induced TPR domain constriction, which is mediated by
the displacement of some TPR segments. The conformational
changes proved even more drastic in the 3-helix bundle domain,
which underwent a rotation of around 155u in relation to the
position observed in the peptide-free RapF structures (Figures 6A
and S4). The 3-helix bundle location observed in crystal was
genuinely induced by the peptide and was not promoted by lattice
contacts given that this domain was solvent-exposed (the solvent
content of the RapF-PhrF crystals was 75%) and participated
minimally in crystal packing. Since PhrF was recognized by the
TPR domain, we compared the underlying structural parameters
of the superhelical coil arrangement of this domain in the RapF
structures. Our analysis shows that the superhelical pitch was
reduced by ,7 A˚ in the PhrF complex, approaching the TPR1–
TPR3 motifs to the remaining TPR segments (Figure 6). This
superhelix pitch reduction was reflected in the apical portion of the
TPR channel, where the TPR domain width was reduced by more
than 10 A˚ in the PhrF complex (from 23 A˚ to 11 A˚) by the
channel narrowing to about 2,500 A˚3 (Figures 6A and S4).
However, the exposed channel surface increased by about 350 A˚2
(calculated by CASTp) since an additional area was provided by
the 3-helix bundle, which the peptide-induced displacement
placed in the channel (Figures 6 and S4).
It was possible to dissect the rearrangement of the global
domain induced by the peptide into local movements. In this way,
PhrF binding was seen to have a strong effect on the relocation of
the TPR1, TPR2, and TPR3 (residues 98–215) segments,
although TPR4–TPR7 (residues 216–368) underwent minor
movements (Figure 6). The superimposition of the complete
TPR domain (residues 98–368) of both RapF structures yielded a
Figure 4. Peptide specificity. Rap proteins shown an exquisite specificity for their inhibitory peptides as is exemplified by the closely related PhrF
(QRGMI) and PhrC (ERGMT) peptides and their targets RapF and RapC/RapB, respectively. The RapF peptide-binding site is represented in semi-
transparent surface colored in green and red for conserved and variable residues, respectively, among RapF, RapB, and RapC. PhrF is shown in sticks
rendering with carbon atoms colored in cyan for identical positions with PhrC and purple for variable. As in Figure 2, the active center is cut along the
peptide axis and presented in two halves for an easier visualization.
doi:10.1371/journal.pbio.1001511.g004
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Figure 5. Quantification of Phr peptide binding to wild-type and mutational RapF variants and limited proteolysis analysis. (A) RapF
or its mutational variants were incubated with increasing concentrations of PhrF and/or PhrC peptides (0–1.2 mM) and separated by native PAGE. The
band corresponding to the Rap-Phr complex was quantified and represented versus peptide concentration to calculate the apparent constant
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large root mean square deviation (RMSD) of 3.9 A˚. However, the
last four TPR segments (TPR4–TPR7) superimposed extremely
well (RMSD of 0.8 A˚ for 152 residues), unlike the largest
differences (RMSD of 2.6 A˚ for 117 residues) observed for the
first three TPR segments (Figure 6). Therefore, the TPR4–TPR7
segments seemed to be a fix preformed bed where the peptide was
placed. Indeed the side chains of the residues of these TPRs, which
interacted with the peptide, underwent minor movements
(.0.5 A˚) and maintained their conformation in both RapF
structures, except for Arg223, which presented a different rotamer
(Figure 6B). These interactions mainly include those termed herein
as anchoring residues (except Tyr152 from TPR2), which
recognized the peptide main chain, thus supporting that the
TPR4–TPR7 fragment of the Rap proteins preformed the Phr
binding site. In addition, those residues interacting with the side
chains at peptide positions 1 and 4 also presented a fixed
disposition, except for the previously indicated Arg223 in both
RapF structures, and could be considered part of the defined
peptide bed. Conversely, the side chains at positions 2 and 5 of the
peptide faced the TPR segments (TPR1–TPR3), which underwent
major movements after PhrF binding (Figure 6B). To interact with
PhrF, these TPR segments were enforced to displace toward the
peptide binding bed in a rotation movement of about 15 degrees
(calculated by DynDom [36]). RapF TPR3 was displaced by,3 A˚
because of the interactions of residues Gln183, Leu187, and
Asp194 with peptide residues Arg2 and Ile5 (Figure 6B).
Displacement was more marked in TPR2, which moved about
5 A˚ by positioning the side chains of Phe145, Glu149, Tyr152,
and Tyr153 to contact distance of Arg2 and Ile5 (Figure 6B).
TPR2 and TPR3 approached the peptide through a rigid body
movement, which included the side chains of the peptide-
contacting residues, except for Tyr153 from TPR2, whose side
chain acquired a different rotamer to interact with PhrF Arg2 and
Ile5 (Figure 6B). Unexpectedly, TPR1, the unique TPR segment
that did not interact with peptide TPR1, underwent the longest
displacement in the TPR domain dragged by its tight interaction
with TPR2. With a rotation of about 35 degrees (calculated by
DynDom) in relation to TPR2, and with a displacement of around
10 A˚ (Figure 6), TPR1 relocated over the TPR domain and closed
its internal channel. The new position of TPR1 was stabilized by
the interactions between the residues from the TPR1 a1–a2 loop
(110–-118) with the residues from the loops connecting the TPR5–
TPR6 and TPR6–TPR7 motifs (294–299 and 328-–334). As the
TPR1 residues (Arg115, Tyr117, and Leu118) involved in these
interactions mediated the contacts with the residues from the C-
terminal tail (371–374) in the RapF-ComA structure, the
movement of TPR1 toward the peptide binding pocket would
be responsible for the C-terminal tail disorder in the RapF-PhrF
structure.
The pronounced movement of the TPR1 segment triggered by
PhrF is more notorious in the 3-helix bundle. As TPR1 connects
with the 3-helix by the linker region, it is a plausible line of
reasoning that TPR1 movements could be propagated to the 3-
helix bundle by a lever movement of the linker region, which is
involved in ComA recognition, and comprises a long flexible loop
and the a4 helix (Figures 1 and 7A). This short helix (81–91) is
separated from the TPR1 a1 helix by a 3-residues kink (92–94) in
the RapF-ComA structure to form 90 degrees between both
structural elements (Figure 7A). However, the RapF-PhrF
structure revealed that the a4 helix ran almost in parallel to the
TPR1 a1 helix (Figure 7A) after a ,155-degree rotation forced by
the movement of the TPR1 a1 helix. The concomitant rotational
movement of the 3-helix bundle brought this domain over the
channel of the TPR domain (Figures 6A and S4) in a position that
became stabilized through several contacts with the TPR domain,
including the interaction of Tyr66 with the peptide. The rotational
movement was accomplished in a rigid body manner since the
superimposition of this domain in both RapF complexes presented
an extremely good fitting (0.7 A˚ RMSD) (Figure 7A). In the new
disposition, the a3 helix of the 3-helix bundle was located between
linker a4 and the TPR1 a1 helices and, in this way, the original
bundle extended from three to five helices (Figure 7A). Although
the 3-helix bundle presented an almost inverted disposition in each
complex, the interface between the 3-helix bundle and the TPR1
a1 helix involved a similar set of residues, but with swapping
interactions among them. A sequence alignment of all the Raps in
B. subtilis shows that the residues implicated in these contacts were
strictly or highly conserved (one or two changes of the 11 Rap
sequences), which strongly suggests that the contact network and
the orchestrated movements enabled by them, described herein for
RapF, could represent a general mechanism in the Rap family
Molecular Mechanism of RapF Inhibition by PhrF
We have shown that PhrF binding induces drastic movements of
the RapF 3-helix bundle. But, how do these conformational
changes promote RapF inhibition? It has been suggested that Phr
peptides could compete with RRs to bind to a common site [25],
but recent genetic and biochemical experiments support that Phr
peptides and target RRs bind at distinct sites of the Rap proteins
[11]. The structures reported here confirm that the ComA and
PhrF binding sites are independent and corroborate that PhrF
mediates action allosterically by the conformational changes
described in the previous section. Residues from the 3-helix
bundle and the linker region accounted for the binding of ComA
(Figure 1D and 1E) [6], unlike PhrF which was recognized by the
TPR domain. Surprisingly, the movement of the 3-helix bundle
induced by PhrF did not completely occlude the ComA binding
site provided by this domain (Figure 7B). Nonetheless, the 3-helix
bundle relocation induced the unfolding of the two final helix turns
of the a3 helix (residues 67–73), which went on to form part of the
linker region (Figure 7A). In this way, the linker region was six
residues longer in RapF-PhrF and had a reverse disposition
(rotation of about 155 degrees) due to the rotational movement of
3-helix bundle (Figure 7A). Thus, the RapF residues interacting
with ComA from the last turns of the a3 helix and the linker
region had a completely different disposition (Glu68 and Glu71) or
faced the TPR domain (Glu78, Arg80, and Leu81) in the RapF-
PhrF structure. Since these RapF residues provided ,40% of the
interaction surface with ComA, the binding of ComA to RapF-
PhrF would be largely compromised. Actually, the in vitro and in
affinities (Kd). Representative PhrF titration experiments for Rap proteins with (RapF) or without (RapF
N227A) capacity to bind the peptide are shown in
the upper part of the figure. (B–D) Limited proteolysis of wild-type RapF and mutant forms. (B) Wild-type RapF or mutants were incubated with
trypsin in the presence (1 mM) or absence of inhibitory peptides. The reaction were stopped at the indicated time points and analyzed by SDS-PAGE.
The proteolytic fragment analyzed by Edman sequencing is indicated by a white arrowhead. (C) Native gel analysis of RapF trypsin digestion. RapF
was digested for 60 min with trypsin in the presence or the absence of PhrF (1 mM) and analyzed by native gel electrophoresis. Notice that RapF-
PhrF is selectively protected against the trypsin digestion. (D) Trypsin protection is peptide-concentration dependent. RapF was incubated with
increasing concentrations of PhrF and subjected to limited proteolysis with trypsin for 60 min and analyzed by SDS-PAGE. Line labeled with (-)
corresponds to a control without trypsin.
doi:10.1371/journal.pbio.1001511.g005
Phr-Mediated Rap Inhibition
PLOS Biology | www.plosbiology.org 9 March 2013 | Volume 11 | Issue 3 | e1001511
Figure 6. Conformational changes in RapF upon PhrF binding. (A) Superimposition of RapF structures from the PhrF (blue hues) and ComA
(orange hues) [6] complexes. The view shows two cartoon diagrams (90u rotation along the vertical axis). Superimposition reveals a huge (155u)
angular movement of approximation to the TPR domain of the N-terminal portion (darker hues) induced by PhrF (in sticks rendering with carbon
atoms colored in pink) binding. TPR1–TPR3 motifs (bright hues) are displaced towards the TPR4–TPR7 motifs (tint hues) that present an almost fixed
disposition in both structures. Helices are shown as cylinders and labeled for the N-terminal domain. TPR motifs are labeled in the TPR domain. (B)
Detailed view of the conformational changes induced in TPR1–TPR3 (left) and TPR4–TPR7 (right) motifs of RapF upon PhrF binding. TPR motifs are
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vivo assays showing that the single mutation of one of these
residues, Gln78, to alanine significantly impaired RapF-ComA
binding [6] supports this statement. Although the remaining
ComA binding site in the 3-helix bundle was almost conserved,
binding of ComA would be sterically prevented by the relative
disposition of the 3-helix and the TPR domains triggered by PhrF
binding (Figure 7B). All together, the partial disruption and sterical
obstruction of the ComA binding site explain PhrF-induced RapF
inhibition.
In order to experimentally correlate the peptide binding with
the conformational changes observed in the 3-D structure, we
performed a limited proteolysis study of RapF and its mutational
variants in the absence and presence of PhrF and PhrC peptides.
Tryptic proteolysis of RapF gives a major fragment of 35 KDa
(Figure 5B), whose N-terminal sequencing yielded the
‘‘LSDLLLE’’ sequence, corresponding to a cut of trypsin in
Arg80 that generated a C-terminal RapF fragment (Leu81-
Val381) with a theoretical molecular weight of 35.617 Da
(Figures 1E). Arg80 was located in a loop of the linker region,
participated in the ComA binding and was exposed to the solvent
in the RapF free from (Figures 1E and S6). In contrast, the PhrF-
induced displacement of the N-terminal portion of RapF reduced
Arg80 exposition, protecting the protein from tryptic digestion
(Figure S6). The assay was validated using non inhibitory RapF
peptides, such as PhrC (Figure 5B), PhrA, and PhrE (unpublished
data), as controls, but they did not protect against trypsin attack. In
addition, the analysis by native PAGE showed that trypsin
selectively cut the RapF band corresponding to the peptide-free
protein, but not the peptide-bounded protein (Figure 5C),
supporting the connection between peptide binding and the
conformational changes in the N-terminal portion that guards
RapF against digestion. Accordingly, the protective effect of PhrF
was lost in the RapFN277A and RapFD194A mutants, which were
unable to bind the peptide (Figure 5B). The RapFE303K mutant,
represented in ribbon, labeled, and colored in blue and orange hues for RapF in complex with PhrF and ComA, respectively. Interacting amino acids
are shown in sticks, labeled, and colored with carbons in the same color that the corresponding TPR motif. Dashed lines indicate the displacements.
PhrF is shown as a stick model with carbons colored in pink.
doi:10.1371/journal.pbio.1001511.g006
Figure 7. PhrF induced conformational changes disrupt response regulator binding sites. (A) Side (left) and top view (right) of the
superimposition of RapF 3-helix bundle from the PhrF (blue hues) and the ComA (yellow hues) complexes shows that this domain rotates,155u as a
rigid body using the linker region (dark blue and orange for PhrF and ComA complexes, respectively) as a hinge. As a result of the movement a1
helices of TPR1 motif (cyan and dark red for PhrF and ComA complexes, respectively) superimpose but with inverted orientation, extending from
three to five helices the helix bundle in the case of RapF-PhrF complex. (B) RR binding to Rap is impaired in the Phr-induced conformation. Spo0F and
DNA-binding domain of ComA (green and yellow surfaces, respectively) were placed in the RapF-PhrF structure by aligning the 3-helix bundle of
RapF-Spo0F (3Q15) [6] and RapF-ComA (3ULQ) [7] with RapF-PhrF structure. RapF-PhrF is represented in ribbon and colored the N-terminal portion in
magenta and the TPR domain in blue, view from the side (left) and the top (right).
doi:10.1371/journal.pbio.1001511.g007
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with affinity to PhrF and PhrC, was protected by both peptides,
indicating a similar conformational change induced by PhrF and
PhrC (Figure 5B). Finally, the tritation of RapF protection
displayed a similar PhrF concentration-dependent behavior to
RapF peptide-binding affinity (Figure 5A and 5D), confirming the
direct relationship between peptide binding and 3-helix bundle
displacement as inferred from its resistance to be hydrolyzed by
trypsin. By taking our structural and functional data together, both
lines of evidence demonstrate that peptide binding in the TPR
domain induced a conformational change that propagated to the
N-terminal portion of the protein, which adopted a completely
different disposition in the RapF-PhrF complex and was impaired
by ComA binding.
Discussion
Raps are regulatory proteins that modulate the signaling activity
of two component systems in two completely different ways:
dephosphorylation or blocking the DNA-binding activity of their
RR target. Rap proteins are themselves in turn inhibited by
specific Phr peptides, adding an extra level of complexity to this
regulatory mechanism. Despite the extensive sequence conserva-
tion shared by Rap family members, Rap-Phr couples are highly
specific. Recent structural studies have shown the molecular
architecture of these proteins and the mechanism of RR
recognition and inhibition, which involve the Rap N-terminal
portion, independently of the inhibitory mechanism followed by
the Rap protein [6,7]. Here, we present structural and functional
data to elucidate how Rap proteins are inhibited by Phr peptides
at the molecular level. We show how PhrF blocks the interaction of
RapF with its target RR by an allosteric mechanism. By binding to
the TPR domain, this peptide constricts this domain that
propagates to the 3-helix bundle domain, which, in turn, is
relocated by a pronounced rotational movement. The new
disposition of the N-terminal portion partially disrupts the binding
site of the RR, whose binding to the Rap protein is also sterically
impaired by the relative disposition of both the 3-helix bundle and
the TPR domains.
Our structural data confirm the proposed ligand recognition
and regulatory function for the TPR domains in the RNPP
proteins [4]. As previously demonstrated for other RNPP family
members, PlcR and PrgX, the regulatory peptide binds in an
extended conformation to the concave side of the TPR superhelix
[4,9,12]. The conserved asparagine in the RNPP family (Asn227
in RapF) interacts with the PhrF backbone and supports the key
role of this residue in peptide accommodation. The impaired
capacity of RapFN227A to bind PhrF confirms its proposed
structural function in peptide fixation, as previously suggested by
functional assays in RapA and RapC [11]. Six additional RapF
residues (Tyr66, Tyr152, Gln183, Arg223, Gln263, and Asp338)
mediate interactions with the PhrF backbone. The medium
(Arg223, Gln263, and Asp338) or high conservation (Tyr66,
Tyr152, and Gln183) feature of these residues suggests a
predominant participation of these positions in the peptide
binding for all Raps. Indeed, the mutation to alanine of Tyr224
or His260 in RapA (corresponding to RapF Tyr226 and Gln263,
respectively) completely abolishes the capacity to bind PhrA, its
inhibitor peptide, but has no effect on enzymatic activity [11].
Therefore, we named the residues in these positions ‘‘anchor’’
since they should ensure peptide binding in the proper disposition
in the TPR domain of different Raps, irrespectively of the peptide
sequence. Additionally, the position corresponding to the con-
served Asp194 in RapF should also form part of the anchoring
machinery but, in this case, it should interact by a side-chain side-
chain salt-bridge with the conserved positive charge at position 2
of the Phr peptides. The mutation of Asp194 in RapF described
herein or the corresponding aspartic residues of RapA and RapC
can result in proteins that are insensitive to inhibitory peptides, but
which conserve activity toward their target RR [11], thus
supporting the functional role of this residue. In contrast, peptide
discrimination should be accomplished by a set of characteristic
residues of each Rap protein to ensure Rap-peptide specificity.
The RapF-PhrF structure reveals that up to 15 residues might be
implicated in peptide discrimination, thus we called them
‘‘specificity’’ residues. Given the partial sequence conservation of
inhibitory peptides and the fact that the same peptide can inhibit
several Raps (Figure 2B), some of these positions are partially
conserved among different Raps. These residues are spread along
six of the seven TPR motifs, which is in agreement with the
extending peptide disposition. RapF peptide selectivity was relaxed
by mutating only one of these residues (Glu303), which validates
the functionality of the proposed recognition residues. In addition,
the participation of these positions in peptide binding has been
confirmed in RapA by the mutation of two of these residues
(corresponding to RapF Tyr226 and Leu230), which generate
functional RapA variants, although they are completely insensitive
to the PhrA peptide [11]. However a more detailed study, guided
by the structural data provided herein, is required to evaluate each
residue’s particular contribution to the peptide discrimination
process.
The RapF-phrF structure has revealed that peptide binding to
the center of the concave side of the TPR motif triggers an
allosteric mechanism that rearranges the N-terminal RR binding
portion. The drastic conformational changes induced by the
peptide observed in RapF can be anticipated by the extremely
different behavior of RapF and the RapF-PhrF complex in native-
PAGE, gel filtration, or analytical ultracentrifugation [6]. The new
disposition of the 3-helix bundle domain hides and disorders the
RR binding site, and inhibits Rap protein activity. The
mechanism described herein resembles that reported for other
RNPP family members, such as PlcR and PrgX. For these
proteins, the binding of the cognate peptide also induces a closure
of the TPR domain, with the consequent conformational change
in the N-terminal domain. However, some major differences are
seen between these two RNPP members and RapF. First, it has
been reported that RapF and its complex with ComA are
monomers in solution [6], thus PhrF binding does not induce any
change in the oligomeric state of RapF. In contrast, signaling
peptides have a major impact on the quaternary state of PlcR and
PrgX by inducing oligomerization (from dimer to tetramer or
dodecamer) in the former and de-polymerization (form tetramer to
dimer) in the latter [4,9]. Second, the rearrangement experience
for the N-terminal effector domain induced for the peptide in
PrgX and PlcR is moderate if compared with the ,155u rotation
undergone in the case of RapF. Finally, the signaling peptide
induces conformational changes in RapF, which partially disor-
ganize the RR binding site, but no major alterations in the DNA
binding domain are induced by the signaling peptide in PrgX
[9,12]. In short, it seems that the molecular mechanisms of effector
peptides recognition and allosteric regulation are conserved in the
RNPP family, but that the final effect induced in each family
member is apparently quite different.
The structural comparison of RapF-ComA and RapH-Spo0F
shows that both proteins are almost structurally identical, but that
the respective RR binding sites are placed differently. Based on the
structural similarity between both Rap proteins, including the
residues that work as a hinge in the conformation change induced
by the inhibitory peptide, it is worth speculating that RapH can be
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inhibited by a similar allosteric mechanism to that described
herein for RapF. Mapping the RapH residues that conform the
Spo0F binding site onto the RapF-PhrF structure reveals that RR
binding may be sterically precluded if RapH adopts a similar
disposition to RapF-PhrF induced by PhrH (Figure 7B). There-
fore, we anticipate that the molecular mechanism described herein
could be general for Rap proteins as the effector peptides mediate
their inhibitory activity allosterically by promoting a N-terminal
portion conformational change that prevents the RR–Rap
interaction. Additional structures of Rap proteins in complex with
their inhibitory peptides are crucial to generalize the mechanism
described herein.
In conclusion, our results elucidate the molecular mechanism
used by effector peptides to inhibit Rap proteins, and provide
insights into the molecular basis of peptide discrimination and
binding. These data also generate valuable information for the
rational design of tools to study signaling mediated by these
systems. In this way, it is possible to engineer Rap proteins with
wild-type activity that are completely insensitive to their inhibitory
peptides or Rap proteins with relaxed peptide selectivity.
Materials and Methods
Protein Expression and Purification
RapF was amplified from B. subtilis genomic DNA using
oligonucleotide primers RapF59BamHI and RapF39NcoI (Table
S2). The PCR product was purified by agarose electrophoresis,
digested with BanHI and NcoI restriction enzymes and cloned
into the BamHI–NcoI site of pPROEX-HTa plasmid (Invitro-
gen). Similarly, full-length ComA was cloned onto the NcoI–
HindIII site of the pPROEX-HTa vector using oligonucleotide
primers ComA59NcoI and ComA39HindIII (Table S2). The
resulting plasmids, pPROEX-RapF and pPROEX-ComA,
respectively, fused to RapF and ComA, an N-terminal tail
consisting of six histidines (66His), followed by a TEV protease
recognition sequence. RapF and ComA were purified following
an identical protocol. pProEX-RapF or pProeX-ComA was
transformed into Escherichia coli expression strain BL21 RIL
(Novagen). A single colony for each transformation was grown
overnight at 37uC in 100 ml of LB medium supplemented with
100 mg/ml of ampicillin and 33 mg/ml of chloramphenicol. This
culture was used to inoculate 3 l of LB medium containing
ampicillin (100 mg/ml) and chloramphenicol (33 mg/ml), and
was grown at 37uC until cells reached an optical density at
600 nm (OD600) of 0.4; the temperature was set at 30uC. After
30 min, the expression of RapF was induced with isopropyl-ß-D-
thiogalactopyranoside (IPTG) at a final concentration of 0.4 mM
and the culture was incubated for 4 h at 30uC. Cells were then
harvested by centrifugation and the pellet was resuspended in
lysis buffer (20 mM TrisHCl [pH 8], 200 mM NaCl, 10 mM
imidazole) and lysed by sonication on ice. Cell debris was
removed by centrifugation at 10,000 g for 1 h. The supernatant
was filtered through a 0.45 mm syringe filter and loaded onto a
5 ml HisTrap FF (GE Healthcare) and rinsed with lysis buffer
until the baseline stabilized. The 66His proteins were eluted in
lysis buffer supplemented with 200 mM imidazol. The fractions
containing the purest protein evaluated by SDS-PAGE stained
with Coomassie blue were pooled and digested with TEV
protease (50:1 molar ratio protein:TEV) and dialyzed against a
500 times volume of dialysis buffer (20 mM TrisHCl [pH 8],
200 mM NaCl). The sample was concentrated by ultrafiltration
through a 30-KDa microfilter (Millipore) and was loaded in a
Hi-Load Superdex 200 16/60 (GE Healthcare) gel filtration
column equilibrated with dialysis buffer. The purest fractions
judged by SDS-PAGE were pooled, concentrated by ultrafiltra-
tion and stored at 280uC. Typical yields were 20–30 mg
recombinant protein/l of culture medium. Selenomethionine-
substitute (SeMet) RapF was obtained by growing the E. coli
strain in M9 minimal medium supplemented with 0.001%
biotin, selenomethionine (50 mg/ml) as well as amino acids
inhibiting methionine synthesis (isoleucine, leucine, and valine at
50 mg/ml; lysine, phenylalanine, and threonine at 100 mg/ml).
Purification protocol for SeMet protein was identical to the
native protein.
Site-Directed Mutagenesis
Site-directed mutagenesis was performed with the QuikChange
mutagenesis kit (Stratagene) according to the manufacturer’s
instructions. The pPROEX-RapF plasmid carrying the rapF wild-
type gene was used as a template and mutations were introduced
utilizing the oligonucleotides listed in Table S2. Methylated
parental DNA was then degraded by adding 10 units of DpnI
(Fermentas) to each PCR reaction and by incubating for 2 h at
37uC, followed by the transformation of E. coli strain DH5-a.
Positive rapF mutant plasmids were screening by PCR amplifica-
tion and sequencing. Mutant proteins were expressed and purified
as native RapF.
Protein Crystallization and Data Collection
RapF-PhrF crystals were grown by the sitting-drop vapor-
diffusion method at 21uC by mixing an equal volume of RapF-
PhrF (RapF 10 mg/ml, PhrF 1 mM purchased from Genescript)
and reservoir (1 M Ammonium Sulfate, 17% Glycerol, 0.1M Tris
[pH 8.5]). Crystals grew in 2–3 d. For phasing, crystals were
soaked for 24 h in reservoir solution, which also contained
0.01 mM terpyridine platinum. Crystals were directly flash-frozen
in liquid nitrogen. A single-wavelength dataset to a maximum
resolution of 3.8 A˚ from the Pt derivative crystal was collected at
ESRF (Grenoble beamline BM14). A native dataset diffracting to
3.1 A˚ was collected on BL-13 Xaloc beamline (ALBA-Barcelona)
(Table S1).
Native and SeMet crystals of RapF in the free form were grown
by the sitting-drop vapor-diffusion method at 21uC by mixing an
equal volume of RapF at 10 mg/ml with reservoir solution (1.2 M
ammonium sulfate, 0.5 M lithium chloride). Crystals were
cryoprotected in mother solution with 30% sucrose and flash-
frozen in liquid nitrogen. A three wavelengths (peak 0.979 A˚,
inflection 0.9791 A˚, and remote at 0.9074 A˚) MAD experiment to
a maximum resolution of 3.4 A˚ from the SeMet crystal was
collected at ESRF, beamline ID14-1. A native dataset to 2.25 A˚
was collected at ESRF, beamline ID 14-4.
Phase Determination and Refinement
The RapF-PhrF structure was determined by SIRAS using the
data from the native and Pt-derivative RapF-PhrF crystals, which
were isomorphous. Autorickshaw [37] was used to locate heavy
atom, calculate phases, extend phases, and to build the initial
model at a resolution of 3.4 A˚. The final model was generated by
interactive cycles of manual model building with Coot [38] and
computational refinement with Refmac [39]. Free RapF crystal
structure was determined by MAD using the data form the native
and SeMet crystals, which were isomorphous. PHENIX [40] was
used to locate selenium atoms, calculate and extend phases, and to
build the initial model at 2.4 A˚ resolution. The final model at
2.25 A˚ resolution was generated by interactive cycles of manual
model building with Coot [38] and computational refinement with
PHENIX [40]. For both structures, solvent molecules were added
to the final model using the find waters application of Coot [38].
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Refinement statistics and models composition are shown in Table
S1. Stereochemical properties were assessed by Molprobity [41]
and Procheck [42]. Superimpositions were calculated using
Lsqkab implemented in the CCP4 suite [43]. Surface accessibility
was calculated using the CASTp software [32] and domain
movements were calculated by DynDom [36]. Coordinates are
deposited in the RSCB Data Bank under 4I9C and 4I9E for
RapF-PhrF complex and RapF free structures, respectively.
Native Gel Protein Analysis
The formation of complexes was analyzed by native polyacryl-
amide gel electrophoresis (Native-PAGE), similarly to that
described by Salinas et al. [44]. Briefly, mixtures of RapF (WT
and mutants), ComA (10 mM of each protein), or Phr peptides
(0.5 mM), as indicated, were incubated in buffer A (200 mM
NaCl, 50 mM Tris-HCl [pH 8.0]) at room temperature for
30 min, separated by Native-PAGE and visualized by Coomassie
blue staining. The peptide binding constants for RapF,
RapFD194A, RapFN227A, RapFE303K, and RapFE303A were calcu-
lated following the same approach. Reaction mixtures containing
20 mg of protein and peptide concentrations ranging from 50 nM
to 1.2 mM in 20 ml of buffer A were incubated for 15 min at room
temperature. Reactions were separated in 8% acrylamide native
gel (100 V, 4uC, 2 h) and visualized by Coomassie blue staining.
Free protein was quantified using the Multigauge V2.1 software
(Fujifilm) and the fraction of bound protein was estimated by
subtracting free protein from the input protein. Data were plotted
as a fraction of the Phr bound protein versus the Phr
concentration, and were analyzed by the Graphpad prism
software. The midpoint of the transition was taken as the apparent
Kd. To calculate the Kd values, at least three independent
experiments were analyzed.
Limited Proteolysis of Rap Proteins
Wild-type RapF and mutant variants (RapFE303K, RapFE303A,
RapFN227A, and RapFD194A) at a concentration of 1.5 mg/ml
were pre-incubated in lysis buffer (10 mM Tris-HCl [pH 8],
0.1 mM EDTA, 1 mM b-mercaptoethanol, 100 mM NaCl, 5%
glycerol, and 5 mM CaCl2) in the presence (1 mM) or absence of
inhibitory peptides at room temperature for 30 min. The protein
was subjected to proteolysis by trypsin (1:10,000) at 37uC and
aliquots of the reaction mixture were taken after 0, 10, 30, and
90 min of incubation, mixed with SDS–PAGE loading buffer and
immediately boiled to stop the enzyme reaction. Samples were
then separated on 12% acrylamide SDS–PAGE and stained with
Coomassie brilliant blue. For the peptide titration experiments,
RapF was incubated in lysis buffer with increasing concentrations
of PhrF at room temperature for 30 min and subjected to limited
proteolysis with trypsin(1:10,000) at 37uC for 60 min. The
reactions were stopped SDS–PAGE loading buffer and analyzed
by SDS–PAGE.
Thermal-Shift Peptide Binding Assays
The thermal-shift assay was conducted in a 7500 Fast Real-time
PCR System (Applied Biosystems). Final melt conditions were
20 mM Tris-HCl (pH 8), 100 mM NaCl, 20 mM RapF, and 56
SYPRO Orange (Sigma-Aldrich). The final concentration of the
inhibitory peptides was 1 mM when they were present. The assays
were carried out at a final volume of 20 ml in 96-well PCR plates.
Samples were heated at 1uC/min. Fluorescent intensity was
plotted versus temperature and integrated with the GraphPad
Prism 4 software using a Boltzmann model to calculate melting
temperatures.
Supporting Information
Figure S1 Electron density map of RapF-PhrF structure.
View of the 2Fo-Fc electron density map at 3.1 A˚, calculated using
phases from the refined model and contoured at 1 s. The view is
center in the PhrF peptide (carbons in magenta) and also shows
some interacting residues from RapF (carbons in yellow).
(TIF)
Figure S2 RapF free and RapF-ComA structures present
similar conformation. Superimposed RapF structures in the
presence (3ULQ; yellow and orange for RapF and ComA,
respectively) and in the absence (light blue) of ComA binding
domain. Both structures present an extremely similar conforma-
tion with local structural variability around the ComA binding site.
(TIF)
Figure S3 Structural comparison of RNPP family mem-
bers. The structures of B. subtilis RapF-PhrF, B. cereus PlcR-PapR
(2QFC) [4], and Enterococcus faecalis PrgX-cCF10 (2AXU) [9] are
shown in the same view and represented in ribbon with the N-
terminal effector domains colored in white and the TPR domains
in rainbow. The corresponding peptides are shown in sticks
rendering with carbon atoms in pink.
(TIF)
Figure S4 TPR channel is constricted by peptide
binding. Three lateral views of RapF-ComA (upper panel) and
RapF-PhrF (lower panel) structures in surface representation with
N-terminal portion and TPR domain colored in yellow and blue,
respectively. TPR channel surface, as is calculated by CASTp
software [32], is colored in magenta.
(TIF)
Figure S5 Rap peptide specificity is conferred by
particular residues. Model of the close related RapC-PhrC
(left) complex based in the RapF-PhrF (right) structure illustrates
the structural bases of peptide specificity. Hydrogen bond between
RapF Glu303 and PhrF Gln1 (showed as black dashed line) is
substituted by a salt-bridged between the Lys in positions 303 of
RapC and the Glu in position 1 of PhrC (black dashed line).
(TIF)
Figure S6 Arg80 localization in RapF structures. The
position of Arg80 (sticks with carbons colored in pink) is shown in
the structures of free RapF and in complex with ComA and PhrF.
The 3-helix bundle, linker region and TPR domain are colored in
yellow, red, and light blue, respectively. ComA is colored in green
and the ComA residues interacting with Arg80 are shown in sticks
with carbons in green. Arg80-ComA interactions are highlighted
with dashed black lines.
(TIF)
Table S1 Data collection and refinement statistics.
(DOCX)
Table S2 Oligonucleotides.
(DOCX)
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